PRINCIPLE-TIMI 44

PRINCIPLE-TIMI 44 compared prasugrel versus higher loading and maintenance doses of clopidogrel for inhibiting platelet aggregation in patients undergoing elective percutaneous intervention.

PRESENTATIONS

TIMI 44 Slides

PUBLICATIONS

Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease

Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel. Results from PRINCIPLE-TIMI 44

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial

Location 60 Fenwood Road, Suite 7022 / 350 Longwood Avenue, Office Level One, Boston, MA 02115 Phone 800.385.4444 E-mail TIMI@partners.org
%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close